Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan, a generic pharmaceutical company, has announced that its CFO, Edward Borkowski, will transition out of his role over the next several months.
Subscribe to our email newsletter
Mr Borkowski will remain with the company until a successor is named and in place. Mylan has retained the executive recruitment firm Korn/Ferry International to lead the search for Mr Borkowski’s replacement.
Robert Coury, vice chairman and CEO of Mylan, said: “Not only do I want to thank Ed for the commitment he brought to Mylan over the last seven years, I want to commend him for the role he played in supporting me and Mylan during the company’s transformation, especially in helping to build a very strong foundation for the company to grow and in establishing a sound and balanced capital structure.”